Pridinol Mesilate

甲磺酸普立地诺

Report date: 2025/08/25 16:35:42
NME

Base Information

Drug NamePridinol Mesilate
Drug Alias Namepridinolロキシーン甲磺酸二苯哌丙醇Mesilato de pridinol甲磺酸哌二苯丙醇 +[15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsMuscle SpasticityLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsMuscle Spasticity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1968/01/01
Country/TerritoryUnited KingdomEUMainland China +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMuscle SpasticityLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeM03BX03
Related LinksWikipediaKEGG